Algorithmic tool may improve screening of patients for an Alzheimer's clinical trial

A caller blood-based screening algorithm dramatically reduced the fig of unnecessary PET scans needed to enlistee patients astatine hazard of Alzheimer's illness for a objective trial, according to probe from scientists astatine the Keck School of Medicine of USC published successful the diary Alzheimer's & Dementia.